FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

417913002: Product containing precisely calcium carbonate 800 milligram and famotidine 10 milligram and magnesium hydroxide 165 milligram/1 each conventional release chewable tablet (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3761721010 Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet en Synonym Active Entire term case insensitive SNOMED CT core module
3761722015 Product containing precisely calcium carbonate 800 milligram and famotidine 10 milligram and magnesium hydroxide 165 milligram/1 each conventional release chewable tablet (clinical drug) en Fully specified name Active Entire term case insensitive SNOMED CT core module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing precisely calcium carbonate 800 milligram and famotidine 10 milligram and magnesium hydroxide 165 milligram/1 each conventional release chewable tablet (clinical drug) Is a Product containing calcium carbonate and famotidine and magnesium hydroxide false Inferred relationship Existential restriction modifier
Product containing precisely calcium carbonate 800 milligram and famotidine 10 milligram and magnesium hydroxide 165 milligram/1 each conventional release chewable tablet (clinical drug) Has active ingredient Laxative false Inferred relationship Existential restriction modifier
Product containing precisely calcium carbonate 800 milligram and famotidine 10 milligram and magnesium hydroxide 165 milligram/1 each conventional release chewable tablet (clinical drug) Has active ingredient Magnesium false Inferred relationship Existential restriction modifier
Product containing precisely calcium carbonate 800 milligram and famotidine 10 milligram and magnesium hydroxide 165 milligram/1 each conventional release chewable tablet (clinical drug) Has active ingredient Trace element supplementation false Inferred relationship Existential restriction modifier
Product containing precisely calcium carbonate 800 milligram and famotidine 10 milligram and magnesium hydroxide 165 milligram/1 each conventional release chewable tablet (clinical drug) Has active ingredient Famotidine false Inferred relationship Existential restriction modifier
Product containing precisely calcium carbonate 800 milligram and famotidine 10 milligram and magnesium hydroxide 165 milligram/1 each conventional release chewable tablet (clinical drug) Has active ingredient Magnesium hydroxide false Inferred relationship Existential restriction modifier
Product containing precisely calcium carbonate 800 milligram and famotidine 10 milligram and magnesium hydroxide 165 milligram/1 each conventional release chewable tablet (clinical drug) Has active ingredient Magnesium-based antacid false Inferred relationship Existential restriction modifier
Product containing precisely calcium carbonate 800 milligram and famotidine 10 milligram and magnesium hydroxide 165 milligram/1 each conventional release chewable tablet (clinical drug) Has active ingredient Calcium carbonate false Inferred relationship Existential restriction modifier
Product containing precisely calcium carbonate 800 milligram and famotidine 10 milligram and magnesium hydroxide 165 milligram/1 each conventional release chewable tablet (clinical drug) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Product containing precisely calcium carbonate 800 milligram and famotidine 10 milligram and magnesium hydroxide 165 milligram/1 each conventional release chewable tablet (clinical drug) Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Product containing precisely calcium carbonate 800 milligram and famotidine 10 milligram and magnesium hydroxide 165 milligram/1 each conventional release chewable tablet (clinical drug) Is a Product containing famotidine in oral dose form (medicinal product form) false Inferred relationship Existential restriction modifier
Product containing precisely calcium carbonate 800 milligram and famotidine 10 milligram and magnesium hydroxide 165 milligram/1 each conventional release chewable tablet (clinical drug) Has manufactured dose form Conventional release chewable tablet true Inferred relationship Existential restriction modifier
Product containing precisely calcium carbonate 800 milligram and famotidine 10 milligram and magnesium hydroxide 165 milligram/1 each conventional release chewable tablet (clinical drug) Is a Product containing calcium carbonate in oral dose form (medicinal product form) false Inferred relationship Existential restriction modifier
Product containing precisely calcium carbonate 800 milligram and famotidine 10 milligram and magnesium hydroxide 165 milligram/1 each conventional release chewable tablet (clinical drug) Is a TEMPORARY parent for CDs that are not updated false Inferred relationship Existential restriction modifier
Product containing precisely calcium carbonate 800 milligram and famotidine 10 milligram and magnesium hydroxide 165 milligram/1 each conventional release chewable tablet (clinical drug) Has presentation strength denominator unit Tablet true Inferred relationship Existential restriction modifier 1
Product containing precisely calcium carbonate 800 milligram and famotidine 10 milligram and magnesium hydroxide 165 milligram/1 each conventional release chewable tablet (clinical drug) Count of base of active ingredient 3 false Inferred relationship Existential restriction modifier
Product containing precisely calcium carbonate 800 milligram and famotidine 10 milligram and magnesium hydroxide 165 milligram/1 each conventional release chewable tablet (clinical drug) Plays role Laxative therapeutic role true Inferred relationship Existential restriction modifier
Product containing precisely calcium carbonate 800 milligram and famotidine 10 milligram and magnesium hydroxide 165 milligram/1 each conventional release chewable tablet (clinical drug) Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 1
Product containing precisely calcium carbonate 800 milligram and famotidine 10 milligram and magnesium hydroxide 165 milligram/1 each conventional release chewable tablet (clinical drug) Has presentation strength numerator unit milligram true Inferred relationship Existential restriction modifier 2
Product containing precisely calcium carbonate 800 milligram and famotidine 10 milligram and magnesium hydroxide 165 milligram/1 each conventional release chewable tablet (clinical drug) Has presentation strength denominator unit Tablet true Inferred relationship Existential restriction modifier 3
Product containing precisely calcium carbonate 800 milligram and famotidine 10 milligram and magnesium hydroxide 165 milligram/1 each conventional release chewable tablet (clinical drug) Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 2
Product containing precisely calcium carbonate 800 milligram and famotidine 10 milligram and magnesium hydroxide 165 milligram/1 each conventional release chewable tablet (clinical drug) Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 3
Product containing precisely calcium carbonate 800 milligram and famotidine 10 milligram and magnesium hydroxide 165 milligram/1 each conventional release chewable tablet (clinical drug) Has unit of presentation Tablet true Inferred relationship Existential restriction modifier
Product containing precisely calcium carbonate 800 milligram and famotidine 10 milligram and magnesium hydroxide 165 milligram/1 each conventional release chewable tablet (clinical drug) Has presentation strength numerator unit milligram true Inferred relationship Existential restriction modifier 3
Product containing precisely calcium carbonate 800 milligram and famotidine 10 milligram and magnesium hydroxide 165 milligram/1 each conventional release chewable tablet (clinical drug) Has presentation strength denominator unit Tablet true Inferred relationship Existential restriction modifier 2
Product containing precisely calcium carbonate 800 milligram and famotidine 10 milligram and magnesium hydroxide 165 milligram/1 each conventional release chewable tablet (clinical drug) Has presentation strength numerator unit milligram true Inferred relationship Existential restriction modifier 1
Product containing precisely calcium carbonate 800 milligram and famotidine 10 milligram and magnesium hydroxide 165 milligram/1 each conventional release chewable tablet (clinical drug) Is a Product containing only calcium carbonate and famotidine and magnesium hydroxide in oral dose form (medicinal product form) true Inferred relationship Existential restriction modifier
Product containing precisely calcium carbonate 800 milligram and famotidine 10 milligram and magnesium hydroxide 165 milligram/1 each conventional release chewable tablet (clinical drug) Has basis of strength substance Magnesium hydroxide true Inferred relationship Existential restriction modifier 3
Product containing precisely calcium carbonate 800 milligram and famotidine 10 milligram and magnesium hydroxide 165 milligram/1 each conventional release chewable tablet (clinical drug) Has precise active ingredient Magnesium hydroxide true Inferred relationship Existential restriction modifier 3
Product containing precisely calcium carbonate 800 milligram and famotidine 10 milligram and magnesium hydroxide 165 milligram/1 each conventional release chewable tablet (clinical drug) Has precise active ingredient Famotidine true Inferred relationship Existential restriction modifier 1
Product containing precisely calcium carbonate 800 milligram and famotidine 10 milligram and magnesium hydroxide 165 milligram/1 each conventional release chewable tablet (clinical drug) Has presentation strength numerator value 10 false Inferred relationship Existential restriction modifier 1
Product containing precisely calcium carbonate 800 milligram and famotidine 10 milligram and magnesium hydroxide 165 milligram/1 each conventional release chewable tablet (clinical drug) Has precise active ingredient Calcium carbonate true Inferred relationship Existential restriction modifier 2
Product containing precisely calcium carbonate 800 milligram and famotidine 10 milligram and magnesium hydroxide 165 milligram/1 each conventional release chewable tablet (clinical drug) Has basis of strength substance Famotidine true Inferred relationship Existential restriction modifier 1
Product containing precisely calcium carbonate 800 milligram and famotidine 10 milligram and magnesium hydroxide 165 milligram/1 each conventional release chewable tablet (clinical drug) Has basis of strength substance Calcium carbonate true Inferred relationship Existential restriction modifier 2
Product containing precisely calcium carbonate 800 milligram and famotidine 10 milligram and magnesium hydroxide 165 milligram/1 each conventional release chewable tablet (clinical drug) Has presentation strength numerator value 165 false Inferred relationship Existential restriction modifier 3
Product containing precisely calcium carbonate 800 milligram and famotidine 10 milligram and magnesium hydroxide 165 milligram/1 each conventional release chewable tablet (clinical drug) Has presentation strength numerator value 800 false Inferred relationship Existential restriction modifier 2

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start